Published in Lancet on July 16, 1983
Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut (1984) 3.18
Duodenal ulcers that will not heal. Gut (1984) 1.45
Evaluation of pirenzepine on gastric acidity in healthy volunteers using ambulatory 24 hour intragastric pH-monitoring. Gut (1985) 1.21
Double blind comparative study of omeprazole 10 mg and 30 mg daily for healing duodenal ulcers. Br Med J (Clin Res Ed) (1985) 1.15
Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man. Gut (1988) 0.97
The effect of omeprazole on gastric emptying in patients with duodenal ulcer disease. Br J Clin Pharmacol (1984) 0.94
Omeprazole: effects on oxidative drug metabolism. Br J Clin Pharmacol (1984) 0.92
Safety of acid-suppressing drugs. Dig Dis Sci (1995) 0.83
Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man. Br J Clin Pharmacol (1985) 0.83
Medical management of peptic ulcer. Postgrad Med J (1984) 0.82
Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Ed) (1983) 0.81
Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients. Gut (1988) 0.78
Mesalazine release from a pH dependent formulation: effects of omeprazole and lactulose co-administration. Br J Clin Pharmacol (1998) 0.75
Resistant duodenal ulcer: when, why and what to do? Postgrad Med J (1988) 0.75
Peptic ulcer disease. Pathophysiology and current medical management. West J Med (1987) 0.75
Optimal reduction of gastric acid secretion in the treatment of peptic ulceration. Drugs (1988) 0.75
A lyophilized aqueous extract of Maytenus ilicifolia leaves inhibits histamine-mediated acid secretion in isolated frog gastric mucosa. Planta (2004) 0.75
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Stressful life events and Graves' disease. Lancet (1991) 3.63
Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28
The complete set of genes encoding major intrinsic proteins in Arabidopsis provides a framework for a new nomenclature for major intrinsic proteins in plants. Plant Physiol (2001) 3.23
Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology (2001) 3.17
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58
International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut (1996) 2.40
Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology (2001) 2.34
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer (1989) 2.30
Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology (2001) 2.30
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst (1990) 2.22
AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology (1998) 2.19
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12
Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11
Venous thromboembolism and cancer. Lancet (1998) 2.08
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06
Monoclonal antibodies for rapid identification of Campylobacter pyloridis. Lancet (1986) 2.04
[Meta-analysis is a good help for literature review. It makes the analysis of earlier studies more efficient and more objective]. Lakartidningen (1999) 2.02
Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol (1995) 2.01
No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease. J Intern Med (2010) 2.01
Pesticides and cancer. Cancer Causes Control (1997) 2.00
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer (1999) 1.97
Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol (1994) 1.96
Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology (1991) 1.93
Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology (2001) 1.87
Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer. J Natl Cancer Inst (1993) 1.87
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83
Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol (2000) 1.82
Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet (1986) 1.79
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun (1989) 1.77
Country profile: Sweden. Lancet (1996) 1.76
Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. J Natl Cancer Inst (1996) 1.71
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer (1997) 1.69
Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68
Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer (2000) 1.67
Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology (1992) 1.65
Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology (1994) 1.64
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res (1999) 1.63
Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst (1995) 1.62
Twin membership and breast cancer risk. Am J Epidemiol (1992) 1.62
Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Am J Epidemiol (1989) 1.62